These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 10496306)

  • 1. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells.
    Colonna M; Nakajima H; Navarro F; López-Botet M
    J Leukoc Biol; 1999 Sep; 66(3):375-81. PubMed ID: 10496306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells.
    Colonna M; Navarro F; Bellón T; Llano M; García P; Samaridis J; Angman L; Cella M; López-Botet M
    J Exp Med; 1997 Dec; 186(11):1809-18. PubMed ID: 9382880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells.
    Borrego F; Kabat J; Kim DK; Lieto L; Maasho K; Peña J; Solana R; Coligan JE
    Mol Immunol; 2002 Feb; 38(9):637-60. PubMed ID: 11858820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory and activating receptors involved in immune surveillance by human NK and myeloid cells.
    Colonna M; Nakajima H; Cella M
    J Leukoc Biol; 1999 Nov; 66(5):718-22. PubMed ID: 10577499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules.
    Cosman D; Fanger N; Borges L; Kubin M; Chin W; Peterson L; Hsu ML
    Immunity; 1997 Aug; 7(2):273-82. PubMed ID: 9285411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel family of inhibitory receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells.
    Colonna M; Navarro F; López-Botet M
    Curr Top Microbiol Immunol; 1999; 244():115-22. PubMed ID: 10453654
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).
    Long EO; Barber DF; Burshtyn DN; Faure M; Peterson M; Rajagopalan S; Renard V; Sandusky M; Stebbins CC; Wagtmann N; Watzl C
    Immunol Rev; 2001 Jun; 181():223-33. PubMed ID: 11513144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paired inhibitory and triggering NK cell receptors for HLA class I molecules.
    López-Botet M; Bellón T; Llano M; Navarro F; García P; de Miguel M
    Hum Immunol; 2000 Jan; 61(1):7-17. PubMed ID: 10658973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones.
    Vitale M; Castriconi R; Parolini S; Pende D; Hsu ML; Moretta L; Cosman D; Moretta A
    Int Immunol; 1999 Jan; 11(1):29-35. PubMed ID: 10050671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets.
    Estefanía E; Flores R; Gómez-Lozano N; Aguilar H; López-Botet M; Vilches C
    J Immunol; 2007 Apr; 178(7):4402-10. PubMed ID: 17371997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killer cell Ig-like receptor-dependent signaling by Ig-like transcript 2 (ILT2/CD85j/LILRB1/LIR-1).
    Kirwan SE; Burshtyn DN
    J Immunol; 2005 Oct; 175(8):5006-15. PubMed ID: 16210603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules.
    Borges L; Hsu ML; Fanger N; Kubin M; Cosman D
    J Immunol; 1997 Dec; 159(11):5192-6. PubMed ID: 9548455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells.
    Fournier N; Chalus L; Durand I; Garcia E; Pin JJ; Churakova T; Patel S; Zlot C; Gorman D; Zurawski S; Abrams J; Bates EE; Garrone P
    J Immunol; 2000 Aug; 165(3):1197-209. PubMed ID: 10903717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules.
    Colonna M; Samaridis J; Cella M; Angman L; Allen RL; O'Callaghan CA; Dunbar R; Ogg GS; Cerundolo V; Rolink A
    J Immunol; 1998 Apr; 160(7):3096-100. PubMed ID: 9531263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes.
    Fanger NA; Cosman D; Peterson L; Braddy SC; Maliszewski CR; Borges L
    Eur J Immunol; 1998 Nov; 28(11):3423-34. PubMed ID: 9842885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
    Rajagopalan S; Long EO
    J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2004 Jun; 172(12):7385-92. PubMed ID: 15187115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockade.
    Godal R; Bachanova V; Gleason M; McCullar V; Yun GH; Cooley S; Verneris MR; McGlave PB; Miller JS
    Biol Blood Marrow Transplant; 2010 May; 16(5):612-21. PubMed ID: 20139023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.